Back
Zenas BioPharma, Inc. Stock Predictions
The Next Phase of AI Is Not About Chat
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
33
ZBIO
Zenas BioPharma, Inc.
Last Price:
$21.80
Seasonality Move:
-2.2%
7 Day Trial
ALL ACCESS PASS
$
7
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiZenas BioPharma, Inc. Stock Forecast
-
Over the next 52 weeks, Zenas BioPharma, Inc. has on average historically fallen by 1.2% based on the past 5 years of stock performance.
-
Zenas BioPharma, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Zenas BioPharma, Inc. Stock Undervalued?The current Zenas BioPharma, Inc. [ZBIO] share price is $21.80. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Zenas BioPharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Zenas BioPharma, Inc. has on average historically fallen by 1.2% based on the past 5 years of stock performance.
Zenas BioPharma, Inc. Stock Rating
Sell
33
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. overpriced?
-
Zenas BioPharma, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Zenas BioPharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
zenasbio.com
52-Week Data
52-Week High:
44.60
52-Week Low:
6.11
Prediction Charts
Market Cap:
912M
Price in USD:
21.80
Volume:
864.3K
Beta:
-1.59
Technical Analysis
SMA50:
29.27
SMA100:
28.22
SMA200:
20.65
52-Wk Change:
177.71%
Stock Predictions
-
Is Zenas BioPharma, Inc. stock public?Yes, Zenas BioPharma, Inc. is a publicly traded company.
-
What is the Zenas BioPharma, Inc. stock quote today?The Zenas BioPharma, Inc. stock price is 21.80 USD today.
-
How to buy Zenas BioPharma, Inc. stock online?You can buy Zenas BioPharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 19.76 | 20.88 | 21.01 | 19.20 |
| Jan-21 | 20.87 | 19.59 | 21.39 | 19.40 |
| Jan-22 | 19.68 | 20.40 | 20.78 | 19.49 |
| Jan-23 | 20.29 | 20.09 | 20.52 | 19.55 |
| Jan-26 | 19.80 | 19.32 | 19.84 | 19.00 |
| Jan-27 | 19.32 | 20.07 | 20.11 | 19.15 |
| Jan-28 | 19.97 | 21.47 | 21.60 | 19.30 |
| Jan-29 | 21.05 | 20.88 | 22.70 | 20.42 |
| Jan-30 | 20.64 | 18.37 | 21.17 | 18.24 |
| Feb-2 | 18.33 | 18.15 | 18.72 | 17.60 |
| Feb-3 | 18.34 | 19.72 | 20.08 | 18.00 |
| Feb-4 | 21.21 | 20.66 | 22.28 | 20.54 |
| Feb-5 | 20.25 | 21.01 | 21.64 | 19.21 |
| Feb-6 | 21.48 | 21.80 | 22.43 | 20.91 |
Zenas BioPharma, Inc. Earnings
Zenas BioPharma, Inc. Earnings Report: Per Share Zenas BioPharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zenas BioPharma, Inc. Forecast Revenue Growth
Zenas BioPharma, Inc. Stock Analysis: Historical quarterly revenues per share for Zenas BioPharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.22 per share.
* Zenas BioPharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.